Breaking the 'Rule of Double Ten': How AI is Revolutionizing Drug Discovery
An in-depth analysis of how AI is shattering the traditional pharmaceutical 'ten years, ten billion dollars' rule, exploring the complete chain revolution from target discovery to clinical trials, and examining how technologies like Insilico Medicine, Exscientia, and AlphaFold are redefining the speed and cost of drug discovery.